The 2021 WHO Classification of CNS Tumors has cancelled the terminology of primary/secondary GBM and AA, and substitutes them with Glioblastoma, IDH-widetype, or Astrocytoma, IDH-mutant, grade 3 and 4. This evidence concerns the gene IDH2 and glioblastoma.